REFERENCES
- O'Brien C P. Benzodiazepine use, abuse, and dependence. J Clin Psychiatry 66, Suppl 2005; 2: 28–33
- Rickels K, Schweizer E, Espana Garcia F, Case G, DeMartinis N, Greenblatt D. Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: Effects on withdrawal symptoms and taper outcome. Psychopharmacology 1999; 141: 1–5
- Di Costanzo E, Rovea A. The prophylaxis of benzodiazepine withdrawal syndrome in the elderly: The effectiveness of carbamazepine. Double-blind study vs. placebo. Minerva Psichiatr 1992; 33: 301–304
- Zullino D F, Khazaal Y, Hattenschwiler J, Borgeat F, Besson J. Anticonvulsant drugs in the treatment of substance withdrawal. Drugs Today 2004; 40: 603–619
- Schmidt D, Elger C E. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?. Epilepsy Behav 2004; 5: 627–635
- Beydoun A. Safety and efficacy of oxcarbazepine: Results of randomized, double-blind trials. Pharmacotherapy 2000; 20: 152–158
- Pellock J M. Treatment of epilepsy in the new millennium. Pharmacotherapy 2000; 20: 129–138
- Beydoun A, Kutluay E. Oxcarbazepine. Expert Opin Pharmacother 2002; 3: 59–71
- Croissant B, Scherle T, Diehl A, Heinz A, Mann K. Oxcarbazepine in alcohol relapse prevention—A Case Series. Pharmacopsychiat 2004; 37: 306–307
- Croissant B, Diehl A, Klein O, Zambrano S, Nakovics H, Heinz A, Mann K. A pilot study of Oxcarbazepine vs. Acamprosate in alcohol-dependent patients. Alcohol Clin Exp Res 2006; 30: 630–635
- Martinotti G, Di Nicola M, Romanelli R, Andreoli S, Pozzi G, Moroni N, Janiri L. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients. Hum Psychopharmacol 2007; 22: 149–156
- Martinotti G, Romanelli R, Di Nicola M, Reina D, Mazza M, Janiri L. Oxcarbazepine at high dosages for the treatment of alcohol dependence. Am J Addict 2007; 16: 247–248
- Koethe D, Juelicher A, Nolden B M, Braunwarth W D, Klosterkötter J, Niklewski G, Wodarz N, Klatt J, Burtscheidt W, Gaebel W, Leweke F M. Oxcarbazepine—Efficacy and tolerability during treatment of alcohol withdrawal. A double-blind, randomized, placebo-controlled multicenter pilot study. Alcohol Clin Exp Res 2007; 31: 1188–1194
- Hermann D, Klages E, Croissant B. Oxcarbazepine in outpatient benzodiazepine withdrawal in polytoxicomanic patients during an opiate maintenance therapy. Psychopharmakotherap 2005; 12: 97–99
- Croissant B, Grosshans M, Klein O, Diehl A, Mann K. Scheme-based Benzodiazepine detoxification with Oxcarbazepine—A case report. Pharmacopsychiatry 2005; 38(5)222–223
- Ashton C H. Benzodiazepine abuse. Drinks, Drugs and Dependence: From Science to Clinical Practice, W Caan, J De Belleroche. Routledge, London 2002; 197–212
- Sullivan J T, Sykora K, Schneiderman J, Naranjo C A, Sellers E M. Assessment of alcohol withdrawal: The revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 1989; 84: 1353–1357
- Laux G, König W. Benzodiazepine abuse—Findings from a German state mental hospital. Schweiz Med Prax 1989; 78: 779–783
- Dietrich D E, Kropp S, Emrich H M. Oxcarbazepine in affective and schizoaffective disorders. Pharmacopsychiat 2001; 34: 242–250
- Ghaemi S N, Berv D A, Klugman J, Rosenquist K J, Hsu D J. Oxcarbazepine treatment of bipolar disorder. J Clin Psychiatry 2003; 64: 943–945
- Ashton C H. The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry 2005; 28: 249–255